{"title":"慢性胰腺炎合并冠心病患者血纤溶活性的特点","authors":"D. Gontsaryuk","doi":"10.33149/VKP.2018.02.06","DOIUrl":null,"url":null,"abstract":"The article presents the original data indicating changes in the fibrinolytic potential in patients with comorbidity of chronic pancreatitis and coronary heart disease. The results indicate that the increased proteolytic capacity (due to the decreased fibrinolysis) and generalization of the atherosclerotic process, activating chronic DIC-syndrome may be considered as factors aggravating the clinical course of chronic pancreatitis, coronary heart disease and chronic cardiac insufficiency, as they promote the risk of cardiovascular events and ischemic pancreatitis.","PeriodicalId":124329,"journal":{"name":"Bulletin of the Club of Pancreatologists","volume":"108 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Peculiarities of blood fibrinolytic activity in patients with comorbidity of chronic pancreatitis and coronary heart disease\",\"authors\":\"D. Gontsaryuk\",\"doi\":\"10.33149/VKP.2018.02.06\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The article presents the original data indicating changes in the fibrinolytic potential in patients with comorbidity of chronic pancreatitis and coronary heart disease. The results indicate that the increased proteolytic capacity (due to the decreased fibrinolysis) and generalization of the atherosclerotic process, activating chronic DIC-syndrome may be considered as factors aggravating the clinical course of chronic pancreatitis, coronary heart disease and chronic cardiac insufficiency, as they promote the risk of cardiovascular events and ischemic pancreatitis.\",\"PeriodicalId\":124329,\"journal\":{\"name\":\"Bulletin of the Club of Pancreatologists\",\"volume\":\"108 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-06-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bulletin of the Club of Pancreatologists\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33149/VKP.2018.02.06\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of the Club of Pancreatologists","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33149/VKP.2018.02.06","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Peculiarities of blood fibrinolytic activity in patients with comorbidity of chronic pancreatitis and coronary heart disease
The article presents the original data indicating changes in the fibrinolytic potential in patients with comorbidity of chronic pancreatitis and coronary heart disease. The results indicate that the increased proteolytic capacity (due to the decreased fibrinolysis) and generalization of the atherosclerotic process, activating chronic DIC-syndrome may be considered as factors aggravating the clinical course of chronic pancreatitis, coronary heart disease and chronic cardiac insufficiency, as they promote the risk of cardiovascular events and ischemic pancreatitis.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
